Photo: Brad Spellberg, M.D., appointed as Chief Medical Officer, Los Angeles County-University of Southern California (LAC + USC)
Highly regarded infectious disease specialist Brad Spellberg, M.D., has been appointed chief medical officer of the Los Angeles County+University of Southern California (LAC+USC) Medical Center and professor of medicine and associate dean for clinical affairs at the Keck School of Medicine of USC, effective July 1.
Spellberg is both an accomplished clinician-scientist and an experienced clinical leader. He joins the Keck School of Medicine from the David Geffen School of Medicine at UCLA, where he held the rank of professor of medicine at the Harbor-UCLA Medical Center and served as associate medical director for npatient Services and associate program director for the Internal Medicine Residency Training Program.
Spellberg’s laboratory studies drug-resistant infections in an effort to develop vaccines and immune therapies to prevent and treat them. He is principal investigator or co-principle investigator on six National Institutes of Health (NIH) grants, of which two are R01 awards. He has also worked closely with the Infectious Diseases Society of America (IDSA) to focus public attention on the increase of antibiotic resistance and decrease of new antibiotic development.
While at Harbor-UCLA, Spellberg spearheaded numerous successful quality and operational improvement initiatives. He also serves as the Department of Health Services physician champion for ICD-10 implementation, which will be of increasing importance during the coming year.
Spellberg earned a B.A. in molecular cell biology-immunology summa cum laude from the University of California, Berkeley before earning his medical degree at the David Geffen School of Medicine at UCLA. He completed his residency in internal medicine at Harbor-UCLA, with a subspecialty fellowship in infectious diseases. As a medical student, he and his classmate, Carlos Ayala, M.D., wrote Boards and Wards, a review for medical students preparing for clinical rotations and for the USMLE Steps 2 and 3.
Spellberg’s extensive clinical research experience includes serving as Chair of the Gram Negative Committee and as a Steering Committee member of the Antibiotic Resistance Leadership Group, which leads a new national NIH-funded clinical research consortium. He has testified before Congress. He is author of Rising Plague: The Global Threat from Deadly Bacteria and Our Dwindling Arsenal to Fight Them, the award-winning book written to inform and educate the public about the crisis in antibiotic resistant infections and lack of antibiotic development.